Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

References

• HendleyJOClinical practice. Otitis mediaN Engl J Med2002347151169117412374878
   PubMed Web of Science ®Google Scholar
• https://www.who.int/immunization/monitoring_surveillance/burden/estimates/Pneumo_hib/en/Accessed October 16, 2017
   Google Scholar
• https://www.who.int/medicines/areas/priority_medicines/Ch6_22Pneumo.pdfAccessed October 16, 2017
   Google Scholar
• DochezARAveryOTVarieties of pneumococcus and their relation to lobar pneumoniaJ Exp Med19152111413219867855
   PubMedGoogle Scholar
• HeffronRPneumonia, with Special Reference to Pneumococcus Lobar PneumoniaCambridge, MAHarvard University Press1939
   Google Scholar
• DrijkoningenJJRohdeGGPneumococcal infection in adults: burden of diseaseClin Microbiol Infect201420Suppl 5455124313448
   PubMed Web of Science ®Google Scholar
• WelteTTorresANathwaniDClinical and economic burden of community-acquired pneumonia among adults in EuropeThorax201267717920729232
   PubMed Web of Science ®Google Scholar
• EndemanHSchelfhoutVVoornGPvan Velzen-BladHGruttersJCBiesmaDHClinical features predicting failure of pathogen identification in patients with community acquired pneumoniaScand J Infect Dis20084071572019086245
   PubMed Web of Science ®Google Scholar
• PrideMWHuijtsSMWuKValidation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urineClin Vaccine Immunol20121981131114122675155
   PubMed Web of Science ®Google Scholar
• HuijtsSMPrideMWVosJMDiagnostic accuracy of a serotype-specific antigen test in community-acquired pneumoniaEur Respir J20134251283129023397295
   PubMed Web of Science ®Google Scholar
• van MensSPMeijvisSCEndemanHLongitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods aloneClin Vaccine Immunol201118579680121367978
   PubMedGoogle Scholar
• RendonARendon-RamirezEJRosas-TaracoAGRelevant cytokines in the management of community-acquired pneumoniaCurr Infect Dis Rep2016181026874956
   PubMed Web of Science ®Google Scholar
• McCullohRJPatelKRecent developments in pediatric community-acquired pneumoniaCurr Infect Dis Rep2016181426960931
   PubMed Web of Science ®Google Scholar
• PletzMWRohdeGGWelteTKolditzMOttSAdvances in the prevention, management, and treatment of community-acquired pneumoniaF1000Res20165300
   Google Scholar
• WoodheadMBlasiFEwigSGuidelines for the management of adult lower respiratory tract infections – full versionClin Microbiol Infect201117Suppl 6E1E59
   PubMed Web of Science ®Google Scholar
• AlibertiSKayeKSThe changing microbiologic epidemiology of community-acquired pneumoniaPostgrad Med201312563142
   PubMed Web of Science ®Google Scholar
• HernesSSHagenEToftelandSTransthoracic fine-needle aspiration in the aetiological diagnosis of community-acquired pneumoniaClin Microbiol Infect201016790991119681958
   PubMed Web of Science ®Google Scholar
• IdehRCHowieSREbrukeBTransthoracic lung aspiration for the aetiological diagnosis of pneumonia: 25 years of experience from The GambiaInt J Tuberc Lung Dis201115672973521477423
   PubMed Web of Science ®Google Scholar
• ScottJAHallAJThe value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumoniaChest199911661716173210593800
   PubMed Web of Science ®Google Scholar
• GenoKAGilbertGLSongJYPneumococcal capsules and their types: past, present, and futureClin Microbiol Rev201528387189926085553
   PubMed Web of Science ®Google Scholar
• FedsonDSNicolas-SponyLKlemetsPPneumococcal polysaccharide vaccination for adults: new perspectives for EuropeExpert Rev Vaccines2011101143116721810065
   PubMed Web of Science ®Google Scholar
• HausdorffWPBryantJKloekCParadisoPRSiberGRThe contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part IIClin Infect Dis20003012214010619741
   PubMed Web of Science ®Google Scholar
• TanTQMasonEOJrWaldERClinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniaePediatrics20021101612093940
   PubMed Web of Science ®Google Scholar
• ImöhlMReinertRROcklenburgCvan der LindenMAssociation of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal diseaseJ Clin Microbiol20104841291129620107087
   PubMed Web of Science ®Google Scholar
• HachelMLascolsCBouchillonSHiltonBMorgensternDPurdyJSerotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populationVaccine2013314881488723928466
   PubMed Web of Science ®Google Scholar
• AlibertiSManteroMMirsaeidiMBlasiFThe role of vaccination in preventing pneumococcal disease in adultsClin Microbiol Infect201420Suppl 55258
   PubMed Web of Science ®Google Scholar
• RobbinsJBAustrianRLeeCJConsiderations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groupsJ Infect Dis1983148113611596361173
   PubMed Web of Science ®Google Scholar
• DiaoWQShenNYuPXLiuBBHeBEfficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trialsVaccine2016341496150326899376
   PubMed Web of Science ®Google Scholar
• AveryOGoebelWFChemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar protein antigensJ Exp Med19295053355019869645
   PubMedGoogle Scholar
• WhitneyCGFarleyMMHadlerJDecline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccineN Engl J Med2003348181737174612724479
   PubMed Web of Science ®Google Scholar
• FitzwaterSPChandranASantoshamMJohnsonHLThe worldwide impact of the seven-valent pneumococcal conjugate vaccinePediatr Infect Dis J201231550150822327872
   PubMed Web of Science ®Google Scholar
• LexauCALynfieldRDanilaRActive Bacterial Core Surveillance TeamChanging epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccineJAMA2005294162043205116249418
   PubMed Web of Science ®Google Scholar
• van DeursenAMvan MensSPSandersEAInvasive Pneumococcal Disease Sentinel Surveillance Laboratory GroupInvasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the NetherlandsEmerg Infect Dis201218111729173723092683
   PubMed Web of Science ®Google Scholar
• MyintTTMadhavaHBalmerPThe impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature reviewAdv Ther201330212715123397399
   PubMed Web of Science ®Google Scholar
• DaganRSerotype replacement in perspectiveVaccine200927Suppl 3C22C2419545935
   PubMed Web of Science ®Google Scholar
• VestrheimDFSteinbakkMAabergeISCaugantDAPostvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complexClin Vaccine Immunol201219344344522237889
   PubMedGoogle Scholar
• ScottJRHanageWPLipsitchMPneumococcal sequence type replacement among American Indian children: a comparison of pre- and routine-PCV7 erasVaccine201230132376238122094283
   PubMed Web of Science ®Google Scholar
• MillerEAndrewsNJWaightPASlackMPGeorgeRCHerd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort studyLancet Infect Dis2011111076076821621466
   PubMed Web of Science ®Google Scholar
• KimHWLeeSKimKHSerotype 6B from a pneumococcal polysaccharide vaccine induces cross-functional antibody responses in adults to serotypes 6A, 6C, and 6DMedicine (Baltimore)20169537e485427631247
   PubMed Web of Science ®Google Scholar
• GrantLRO’BrienSEBurbidgePComparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypesPLoS One201389e7490624086394
   PubMed Web of Science ®Google Scholar
• VesikariTKarvonenAKorhonenTImmunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae Protein D Conjugate Vaccine when administered as catch-up vaccination to children 7 months to 5 years of agePediatr Infect Dis J2011308e130e14121540760
   PubMed Web of Science ®Google Scholar
• LeeHChoiEHLeeHJEfficacy and effectiveness of extended-valency pneumococcal conjugate vaccinesKorean J Pediatr2014572556624678328
   PubMedGoogle Scholar
• AdlerHFerreiraDMGordonSBRylanceJPneumococcal capsular polysaccharide immunity in the elderlyClin Vaccine Immunol2017246e00004e0001728424198
   PubMedGoogle Scholar
• PrincipiNEspositoSDevelopment of pneumococcal vaccines over the last 10 yearsExpert Opin Biol Ther201818171729022363
   PubMed Web of Science ®Google Scholar
• RijkersGTFixing a hole: preventing pneumococcal pneumonia by vaccinationFront Immunol2016734927679637
   PubMed Web of Science ®Google Scholar
• RijkersGTvan MensSPvan Velzen-BladHWhat do the next 100 years hold for pneumococcal vaccination?Expert Rev Vaccines20109111241124421087102
   PubMed Web of Science ®Google Scholar
• Tin Tin HtarMChristopoulouDSchmittHJPneumococcal serotype evolution in Western EuropeBMC Infect Dis20151541926468008
   PubMed Web of Science ®Google Scholar
• KaurRCaseyJRPichicheroMEEmerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to the 7-valent era, 2006–2015Pediatr Infect Dis J20163590191627420806
   PubMed Web of Science ®Google Scholar
• RichterSSDiekemaDJHeilmannKPDohrnCLRiahiFDoernGVChanges in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United StatesAntimicrob Agents Chemother2014586484648925136018
   PubMed Web of Science ®Google Scholar
• FindlowHBorrowRInteractions of conjugate vaccines and co-administered vaccinesHum Vaccin Immunother20161222623026619353
   PubMed Web of Science ®Google Scholar
• Recommended Adult Immunization Schedule, by Vaccine and Age GroupCenters for Disease Control and PreventionAtlanta, GA2015
   Google Scholar
• MaruyamaTTaguchiONiedermanMSEfficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trialBMJ2010340c100420211953
   PubMed Web of Science ®Google Scholar
• Leventer-RobertsMFeldmanBSBrufmanICohen-StaviCJHoshenMBalicerRDEffectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control studyClin Infect Dis201560101472148025669354
   PubMed Web of Science ®Google Scholar
• Ochoa-GondarOVila-CorcolesARodriguez-BlancoTEffectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥60 years: 3 years of follow-up in the CAPAMIS studyClin Infect Dis201458790991724532544
   PubMed Web of Science ®Google Scholar
• RijkersGTPneumococcal vaccination in elderlyPneumococcal Conjugate Vaccines, Future MedicineLondon, UK20123245
   Google Scholar
• BátoryGJancsóAPuskásERédeiALengyelEAntibody and immunoglobulin levels in aged humansArch Gerontol Geriatr1984321751886476977
   PubMed Web of Science ®Google Scholar
• Romero-SteinerSMusherDMCetronMSReduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidityClin Infect Dis199929228128810476727
   PubMed Web of Science ®Google Scholar
• SimellBVuorelaAEkströmNAging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosisVaccine201129101929193421236231
   PubMed Web of Science ®Google Scholar
• MurrayMAChotirmallSHThe impact of immunosenescence on pulmonary diseaseMediators Inflamm2015201569254626199462
   PubMed Web of Science ®Google Scholar
• PeraACamposCLópezNImmunosenescence: implications for response to infection and vaccination in older peopleMaturitas2015821505526044074
   PubMed Web of Science ®Google Scholar
• KovacsEJBoeDMBouleLACurtisBJInflammaging and the lungClin Geriatr Med201733445947128991644
   PubMed Web of Science ®Google Scholar
• LeeSKimHWLeeJHKimKHFunctional immune responses to 11 non-PCV13 serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adultsVaccine201735374960496528778614
   PubMed Web of Science ®Google Scholar
• van de VosseEvan Ostaijen-Ten DamMMVermaireRRecurrent respiratory tract infections (RRTI) in the elderly: a late onset mild immunodeficiency?Clin Immunol2017180111111928487087
   PubMed Web of Science ®Google Scholar
• RothAGlaesenerSSchützKMeyer-BahlburgAReduced number of transitional and naive B cells in addition to decreased BAFF levels in response to the T cell independent immunogen Pneumovax®23PLoS One2016113e015221527031098
   PubMed Web of Science ®Google Scholar
• HeaneyJLPhillipsACCarrollDDraysonMTSalivary functional antibody secretion is reduced in older adults: a potential mechanism of increased susceptibility to bacterial infection in the elderlyJ Gerontol A Biol Sci Med Sci201570121578158526328602
   PubMed Web of Science ®Google Scholar
• AhnJGKimHWChoiHJLeeJHKimKHFunctional immune responses to twelve serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adultsVaccine201533384770477526277073
   PubMed Web of Science ®Google Scholar
• AwDSilvaABPalmerDBImmunosenescence: emerging challenges for an ageing populationImmunology2007120443544617313487
   PubMed Web of Science ®Google Scholar
• HakEGrobbeeDESandersEARationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adultsNeth J Med200866937838318990781
   PubMed Web of Science ®Google Scholar
• BontenMJHuijtsSMBolkenbaasMPolysaccharide conjugate vaccine against pneumococcal pneumonia in adultsN Engl J Med2015372121114112525785969
   PubMed Web of Science ®Google Scholar
• van WerkhovenCHBontenMJThe Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA): what is the future of pneumococcal conjugate vaccination in elderly?Future Microbiol20151091405141326347153
   PubMed Web of Science ®Google Scholar
• BlackCLWilliamsWWWarnockRPneumococcal vaccination among Medicare beneficiaries occurring after the advisory committee on immunization practices recommendation for routine use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults aged ≥65 yearsMMWR Morb Mortal Wkly Rep2017662772873328704347
   PubMed Web of Science ®Google Scholar
• DirmesropianSWoodJGMacIntyreCRCost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older AustraliansVaccine201735344307431428693751
   PubMed Web of Science ®Google Scholar
• Advisory Committee on Immunization PracticesGrading of Recommendations, Assessment, Development, and Evaluation (GRADE) for pneumococcal vaccines for adults aged ≥65 yearsUS Department of Health & Human Services Available from: https://www-cdc-gov.proxy.library.uu.nl/vaccines/acip/recs/grade/pneumo-vac-adult.htmlAccessed September 29, 2017
   Google Scholar
• McLaughlinJMSwerdlowDLIsturizREJodarLRethinking number-needed-to-vaccinate for pneumococcal conjugate vaccines in older adults: current and future implicationsVaccine201735405360536528863866
   PubMed Web of Science ®Google Scholar
• MangenMJRozenbaumMHHuijtsSMCost-effectiveness of adult pneumococcal conjugate vaccination in the NetherlandsEur Respir J20154651407141626160871
   PubMed Web of Science ®Google Scholar
• OslerWThe Principles and Practice of Medicine Available from: https://archive.org/details/principlesandpr00mccrgoogAccessed September 29, 2017
   Google Scholar
• CookRTAlcohol abuse, alcoholism, and damage to the immune system–a reviewAlcohol Clin Exp Res1998229192719429884135
   PubMed Web of Science ®Google Scholar
• RushBEffects of Ardent Spirits upon the Human Body and Mind, with an Account of the Means of Preventing and of the Remedies for Curing ThemPhiladelphia, PAThomas Dobson1810
   Google Scholar
• CruickshankHCJefferiesJMClarkeSCLifestyle risk factors for invasive pneumococcal disease: a systematic reviewBMJ Open20142046e005224
   Web of Science ®Google Scholar
• RuizMEwigSTorresASevere community-acquired pneumonia. Risk factors and follow-up epidemiologyAm J Respir Crit Care Med1999160392392910471620
   PubMed Web of Science ®Google Scholar
• AlmirallJSerra-PratMBolíbarIBalassoVRisk factors for community-acquired pneumonia in adults: a systematic review of observational studiesRespiration201794329931128738364
   PubMed Web of Science ®Google Scholar
• PodolskySHThe changing fate of pneumonia as a public health concern in 20th-century America and beyondAm J Public Health200595122144215416257952
   PubMed Web of Science ®Google Scholar
• MortensenEMKapoorWNChangCCFineMJAssessment of mortality after long-term follow-up of patients with community-acquired pneumoniaClin Infect Dis200337121617162414689342
   PubMed Web of Science ®Google Scholar
• https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_04.pdfAssessed October 19, 2017
   Google Scholar
• https://www.who.int/medicines/areas/priority_medicines/Ch6_22Pneumo.pdfAssessed October 19, 2017
   Google Scholar
• Beck-SagueCBanerjeeSJarvisWRInfectious diseases and mortality among US nursing home residentsAm J Public Health19938312173917428259806
   PubMed Web of Science ®Google Scholar
• DhawanNPandyaNKhaliliMPredictors of mortality for nursing home-acquired pneumonia: a systematic reviewBiomed Res Int2015201528598325821793
   PubMed Web of Science ®Google Scholar
• MarrieTJPneumoniaClin Geriatr Med1992847217341423131
   PubMedGoogle Scholar
• Corrales-MedinaVFMusherDMShachkinaSChirinosJAAcute pneumonia and the cardiovascular systemLancet2013381986549650523332146
   PubMed Web of Science ®Google Scholar
• RamirezJAlibertiSMirsaeidiMAcute myocardial infarction in hospitalized patients with community-acquired pneumoniaClin Infect Dis200847218218718533841
   PubMed Web of Science ®Google Scholar
• MortensenEMMeterskyMLLong-term mortality after pneumoniaSemin Respir Crit Care Med201233331932422718218
   PubMed Web of Science ®Google Scholar
• WagenvoortGHSandersEAde MelkerHEvan der EndeAVlaminckxBJKnolMJLong-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumoniaVaccine201735141749175728262334
   PubMed Web of Science ®Google Scholar
• VestjensSMTSpoorenbergSMCRijkersGTHigh-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumoniaRespirology20172251000100628221010
   PubMed Web of Science ®Google Scholar
• CarbonCOptimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity)Chemotherapy200147Suppl 41925
   Web of Science ®Google Scholar
• BajcMNeillyBMiniatiMMortensenJJonsonBMethodology for ventilation/perfusion SPECTSemin Nucl Med201040641542520920632
   PubMed Web of Science ®Google Scholar
• BrownAOOrihuelaCJVisualization of Streptococcus pneumoniae within cardiac microlesions and subsequent cardiac remodelingJ Vis Exp201598
   Google Scholar
• BrownAOMannBGaoGStreptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac functionPLoS Pathog2014109e100438325232870
   PubMed Web of Science ®Google Scholar
• ShenoyATBrissacTGilleyRPStreptococcus pneumoniae in the heart subvert the host response through biofilm-mediated resident macrophage killingPLoS Pathog2017138e100658228841717
   PubMed Web of Science ®Google Scholar
• ReyesLFRestrepoMIHinojosaCASevere pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodelingAm J Respir Crit Care Med2017196560962028614669
   PubMed Web of Science ®Google Scholar
• MusherDMRuedaAMKakaASMaparaSMThe association between pneumococcal pneumonia and acute cardiac eventsClin Infect Dis200745215816517578773
   PubMed Web of Science ®Google Scholar
• PerryTWPughMJWatererGWIncidence of cardiovascular events after hospital admission for pneumoniaAm J Med2011124324425121396508
   PubMed Web of Science ®Google Scholar
• FeldmanCAndersonRPrevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumoniaPneumonia201681128702290
   PubMedGoogle Scholar
• MeijvisSCHardemanHRemmeltsHHDexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trialLancet201137797822023203021636122
   PubMed Web of Science ®Google Scholar
• VissinkCEHuijtsSMde WitGABontenMJMangenMJHospitalization costs for community-acquired pneumonia in Dutch elderly: an observational studyBMC Infect Dis20161646627589847
   PubMed Web of Science ®Google Scholar
• KaplanVAngusDCGriffinMClermontGWatsonRSLinde-ZwirbleWTHospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United StatesAm J Respir Crit Care Med200216576677211897642
   PubMed Web of Science ®Google Scholar
• DeFrancesCJLucasCABuleVCGolosinskiyA2006 National Hospital discharge surveyNatl Health Stat Rep200830120
   Google Scholar
• MeterskyMLMaAHouckPMBratzlerDWAntibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolonesChest200713146647317296649
   PubMed Web of Science ®Google Scholar
• RestrepoMIMortensenEMVelezJAFreiCAnzuetoAA comparative study of community-acquired pneumonia patients admitted to the ward and the ICUChest200813361061717989157
   PubMed Web of Science ®Google Scholar
• HallMJDeFrancesCJWilliamsSNNational Hospital Discharge survey: 2007 summaryNatl Health Stat Report201029121
   PubMedGoogle Scholar
• OstermannHGarauJMedinaJPascualEMcBrideKBlasiFREACH study groupResource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH studyBMC Pulm Med2014143624593248
   PubMed Web of Science ®Google Scholar
• TichopadARobertsCGembulaIClinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and SlovakiaPLoS One201388e7137523940743
   PubMed Web of Science ®Google Scholar
• SatoRGomez ReyGNelsonSPinskyBCommunity-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 yearsAppl Health Econ Health Policy201311325125823605251
   PubMedGoogle Scholar
• YuHRubinJDunningSLiSSatoRClinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service populationJ Am Geriatr Soc201260112137214323110409
   PubMed Web of Science ®Google Scholar
• ThomasCPRyanMChapmanJDIncidence and cost of pneumonia in medicare beneficiariesChest2012142497398122406959
   PubMed Web of Science ®Google Scholar
• JacobCMittendorfTGraf von der SchulenburgJMKrankheitskosten sowie gesundheitsbezogene Lebensqualität (hrQoL) bei ambulant erworbener Pneumonie (CAP) - ein systematisches [Costs of illness and health-related quality of life for community-acquired pneumonia–a systematic review]Pneumologie2011658498502 German21512972
   PubMedGoogle Scholar
• SpoorenbergSMBosWJHeijligenbergRMicrobial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysisBMC Infect Dis20141433524938861
   PubMed Web of Science ®Google Scholar
• WelteRFeenstraTJagerHLeidlRA decision chart for assessing and improving the transferability of economic evaluation results between countriesPharmacoeconomics2004221385787615329031
   PubMed Web of Science ®Google Scholar
• PeetersCCTenbergen-MeekesAMHaagmansBPneumococcal conjugate vaccinesImmunol Lett19913022672741757114
   PubMed Web of Science ®Google Scholar
• RodenburgGDde GreeffSCJansenAGEffects of pneumococcal conjugate vaccine 2 years after its introduction, the NetherlandsEmerg Infect Dis201016581682320409372
   PubMed Web of Science ®Google Scholar
• Wikimedia Commons [homepage on the internet]Jheronimus Bosch Gallery. 2.1.17 The Hermit Saints Triptych Available from: https://commons.wikimedia.org/wiki/Jheronimus_Bosch#The_Hermit_Saints_TriptychAccessed March 9, 2018
   Google Scholar
• UN Data [homepage on the internet]Per capita GDP at current prices Available from: http://data.un.org/Data.aspx?q=GDP+per+capita&d=SNAAMA&f=grID%3a101%3bcurrID%3aUSD%3bpcFlag%3a1Accessed March 9, 2018
   Google Scholar